| 000 | 01759 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514182800.0 | ||
| 264 | 0 | _c20040812 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdh144 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMitchell, P L R | |
| 245 | 0 | 0 |
_aA phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2004 |
||
| 300 |
_a585-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aTaxoids _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBasser, R | |
| 700 | 1 | _aChipman, M | |
| 700 | 1 | _aGrigg, A | |
| 700 | 1 | _aMansfield, R | |
| 700 | 1 | _aCebon, J | |
| 700 | 1 | _aDavis, I D | |
| 700 | 1 | _aAppia, F | |
| 700 | 1 | _aGreen, M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 15 _gno. 4 _gp. 585-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdh144 _zAvailable from publisher's website |
| 999 |
_c14751344 _d14751344 |
||